LEADER 04335nam  22006255  450 
001 9910409684003321
005 20200701101212.0
010   $a981-15-2017-8
024 7 $a10.1007/978-981-15-2017-4
035   $a(CKB)5300000000003590
035   $a(DE-He213)978-981-15-2017-4
035   $a(MiAaPQ)EBC6129273
035   $a(PPN)243224222
035   $a(EXLCZ)995300000000003590
100   $a20200304d2020      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTheranostics Approaches to Gastric and Colon Cancer /$fedited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar
205   $a1st ed. 2020.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020.
215   $a1 online resource (XIII, 250 p. 26 illus., 17 illus. in color.)
225 1 $aDiagnostics and Therapeutic Advances in GI Malignancies,$x2662-2688
311   $a981-15-2016-X 
327   $aChapter 1. Therapeutic role of Phytochemicals in Colorectal cancer -- Chapter 2. Adiponectin Signaling In Colorectal Cancer -- Chapter 3. Role of Matrix Metalloproteinases in Colorectal Cancer -- Chapter 4. The Role of Hypoxia-Inducible Factor 1- Alpha in Colorectal Cancer -- Chapter 5. Mechanisms and pathways of metabolic reprogramming of colorectal cancer -- Chapter 6. Targeting metabolic reprogramming of colorectal cancer -- Chapter 7. Understanding colorectal cancer: the basics -- Chapter 8. Molecular signaling pathways involved in gastric cancer chemoresistance -- Chapter 9. Meta-analysis reveals no significant association of EPHX1 Tyr113His and His139Arg polymorphisms with the colorectal cancer risk -- Chapter 10. Meta-analysis of genetic variants in alcohol metabolizing enzymes and their association with colorectal cancer risk -- Chapter 11. Gut microbiota as signatures in non-communicable diseases and mucosal immunity -- Chapter 12. Immunotherapy for Colon Cancer: Recent Perspectives -- Chapter 13. Nanotechnology Applications in Gastric cancer. .
330   $aThis book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.
410  0$aDiagnostics and Therapeutic Advances in GI Malignancies,$x2662-2688
606   $aCancer research
606   $aGastroenterology 
606   $aOncology  
606   $aGenetics
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
606   $aGastroenterology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33061
606   $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160
606   $aGenetics and Genomics$3https://scigraph.springernature.com/ontologies/product-market-codes/L32000
615  0$aCancer research.
615  0$aGastroenterology .
615  0$aOncology  .
615  0$aGenetics.
615 14$aCancer Research.
615 24$aGastroenterology.
615 24$aOncology.
615 24$aGenetics and Genomics.
676   $a616.99433
702   $aRaju$b Ganji Seeta Rama$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aBhaskar$b L.V.K.S$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910409684003321
996   $aTheranostics Approaches to Gastric and Colon Cancer$92528919
997   $aUNINA